TREATMENT READING
Rare Cancers of Childhood
Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.
Not medical advice · Not a complete treatment or trial directory
Made by Triangle.
Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
78 sections
- General Information About Rare Cancers of Childhood
- Introduction
- Head and Neck Cancers
- Nasopharyngeal Carcinoma
- Esthesioneuroblastoma
- Thyroid Tumors
- Oral Cavity Cancer
- Salivary Gland Tumors
- Laryngeal Cancer and Papillomatosis
- NUT Carcinoma
- Thoracic Cancers
- Breast Cancer
- Lung Cancer
- Pulmonary Inflammatory Myofibroblastic Tumors
- Tracheobronchial Tumors
- Pleuropulmonary Blastoma
- Esophageal Cancer
- Thymoma and Thymic Carcinoma
- Cardiac Tumors
- Abdominal Cancers
- Adrenocortical Carcinoma
- Gastric Cancer
- Pancreatic Cancer
- Colorectal Cancer
- Gastrointestinal Neuroendocrine Tumors
- Gastrointestinal Stromal Tumors (GIST)
- Genital/Urinary Tumors
- Bladder Cancer
- Testicular Cancer (Non–Germ Cell)
- Ovarian Cancer (Non–Germ Cell)
- Cervical and Vaginal Cancer
- Other Rare Childhood Cancers
- Mesothelioma
- Multiple Endocrine Neoplasia (MEN) Syndromes
- Pheochromocytoma and Paraganglioma
- Skin Cancer (Melanoma, Basal Cell Carcinoma [BCC], and Squamous Cell Carcinoma [SCC])
- Melanoma
- BCC and SCC
- Intraocular (Uveal) Melanoma
- Chordoma
- Cancer of Unknown Primary (CUP) Site
- General Information About Rare Cancers of Childhood
- Key Points
- Rare cancers of childhood are cancers not usually seen in children.
- Rare Cancers of the Head and Neck
- Nasopharyngeal Cancer
- Esthesioneuroblastoma
- Thyroid Cancer
- Oral Cavity Cancer
- Salivary Gland Tumors
- Laryngeal Cancer and Papillomatosis
- NUT Carcinoma
- Rare Cancers of the Chest
- Breast Cancer
- Lung Cancer
- Esophageal Cancer
- Thymoma and Thymic Carcinoma
- Heart Tumors
- Rare Cancers of the Abdomen
- Adrenocortical Carcinoma
- Stomach Cancer
- Pancreatic Cancer
- Colorectal Cancer
- Gastrointestinal Neuroendocrine Tumors
- Gastrointestinal Stromal Tumors
- Rare Cancers of the Reproductive and Urinary Systems
- Bladder Cancer
- Testicular Cancer
- Ovarian Cancer
- Cervical and Vaginal Cancers
- Other Rare Cancers of Childhood
- Mesothelioma
- Multiple Endocrine Neoplasia Syndromes
- Pheochromocytoma and Paraganglioma
- Skin Cancer (Melanoma, Basal Cell Carcinoma, and Squamous Cell Carcinoma of the Skin)
- Intraocular (Uveal) Melanoma
- Chordoma
- Carcinoma of Unknown Primary
General Information About Rare Cancers of Childhood
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
Introduction
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
Cancer in children and adolescents is rare, although the overall incidence has slowly increased since 1975.[1] Children and adolescents with cancer should be referred to medical centers that have a multidisciplinary team of cancer specialists with experience treating the cancers that occur during childhood and adolescence. This multidisciplinary team approach incorporates the skills of primary care physicians, pediatric surgeons, pathologists, pediatric radiation oncologists, pediatric medical oncologists and hematologists, rehabilitation specialists, pediatric oncology nurses, social workers, child-life professionals, psychologists, nutritionists, and others to ensure that children receive treatment, supportive care, and rehabilitation to achieve optimal survival and quality of life. For specific information about supportive care for children and adolescents with cancer, see the summaries on Supportive and Palliative Care.
Sources: 1 · Supportive and Palliative Care
The American Academy of Pediatrics has outlined guidelines for pediatric cancer centers and their role in the treatment of children and adolescents with cancer.[2] At these centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate is offered to most patients and their families. Clinical trials for children and adolescents diagnosed with cancer are generally designed to compare potentially better therapy with current standard therapy. Other types of clinical trials test novel therapies when there is no standard therapy for a cancer diagnosis. Most of the progress in identifying curative therapies for childhood cancers has been achieved through clinical trials. Information about ongoing clinical trials is available from the NCI website.
Sources: 2 · NCI website
Dramatic improvements in survival have been achieved for children and adolescents with cancer. Between 1975 and 2020, childhood cancer mortality decreased by more than 50%.[3-5] Childhood and adolescent cancer survivors require close monitoring because side effects of cancer therapy may persist or develop months or years after treatment. For information about the incidence, type, and monitoring of late effects in childhood and adolescent cancer survivors, see Late Effects of Treatment for Childhood Cancer.
Sources: 3 · 5 · Late Effects of Treatment for Childhood Cancer
Childhood cancer is a rare disease, with about 15,000 cases diagnosed annually in the United States in individuals younger than 20 years.[6] The U.S. Rare Diseases Act of 2002 defines a rare disease as one that affects populations smaller than 200,000 people. Therefore, all pediatric cancers are considered rare.
Sources: 6 · Rare Diseases Act of 2002
The designation of a rare tumor is not uniform among pediatric and adult groups. In adults, rare cancers are defined as those with an annual incidence of fewer than six cases per 100,000 people. They account for up to 24% of all cancers diagnosed in the European Union and about 20% of all cancers diagnosed in the United States.[7,8] In children and adolescents, the designation of a rare tumor is not uniform among international groups, as follows:
A consensus effort between the European Union Joint Action on Rare Cancers and the European Cooperative Study Group for Rare Pediatric Cancers (EXPeRT) estimated that 11% of all cancers in patients younger than 20 years could be categorized as very rare. This consensus group defined very rare cancers as those with annual incidences of fewer than 2 cases per 1 million people. However, three additional histologies (thyroid carcinoma, melanoma, and testicular cancer) with incidences of more than 2 cases per 1 million people were also included in the very rare group due to a lack of knowledge and expertise in the management of these tumors.[9]
Sources: 9
The Children's Oncology Group (COG) defines rare pediatric cancers as those listed in the International Classification of Childhood Cancer subgroup XI, which includes thyroid cancers, melanomas and nonmelanoma skin cancers, and multiple types of carcinomas (e.g., adrenocortical carcinomas, nasopharyngeal carcinomas, and most adult-type carcinomas such as breast cancers and colorectal cancers).[10] These diagnoses account for about 5% of the cancers diagnosed in children aged 0 to 14 years and about 27% of the cancers diagnosed in adolescents aged 15 to 19 years.[4] Most cancers in subgroup XI are either melanomas or thyroid cancers, with other cancer types accounting for only 2% of the cancers in children aged 0 to 14 years and 9.3% of the cancers in adolescents aged 15 to 19 years.
These rare cancers are extremely challenging to study because of the relatively few patients with any individual diagnosis, the predominance of rare cancers in the adolescent population, and the small number of clinical trials for adolescents with rare cancers.
Some investigators have used large databases, such as the Surveillance, Epidemiology, and End Results (SEER) Program and the National Cancer Database, to gain more insight into these rare childhood cancers. However, these database studies are limited. Several initiatives to study rare pediatric cancers have been developed by the COG and other international groups, including the Société Internationale D'Oncologie Pédiatrique (SIOP). The Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) rare tumor project was founded in Germany in 2006.[11] The Italian Tumori Rari in Eta Pediatrica (TREP) group was launched in 2000,[12] and the Polish Pediatric Rare Tumor Study Group was launched in 2002.[13] In Europe, the rare tumor study groups from France, Germany, Italy, Poland, and the United Kingdom joined to become the EXPeRT group, focusing on international collaboration and analyses of specific rare tumor entities.[14] Within the COG, efforts have concentrated on increasing accrual to COG registries (Project Every Child) and tumor banking protocols, developing single-arm clinical trials, and increasing cooperation with adult cooperative group trials.[15] The accomplishments and challenges of this initiative have been described in detail.[10,16]
The tumors listed in this summary are very diverse. They are arranged in descending anatomic order, from infrequent tumors of the head and neck to rare tumors of the urogenital tract and skin. All of these cancers are rare enough that pediatric hospitals might see less than a handful of some histologies in several years. Most of the histologies listed here occur more frequently in adults. Information about these tumors may also be found in sources relevant to adults with cancer.
The Rare Cancers of Childhood Treatment summary has been separated into individual summaries for each topic. Please use the lists below or the following link to find the individual summaries: PDQ Cancer Information Summaries: Pediatric Treatment.
Sources: PDQ Cancer Information Summaries: Pediatric Treatment
This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.
Head and Neck Cancers
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
These cancers are seen very infrequently in patients younger than 15 years, and most of the evidence is derived from small case series or cohorts combining pediatric and adult patients.
Childhood sarcomas often occur in the head and neck area and they are described in other summaries. Rare pediatric head and neck cancers include the following:
Nasopharyngeal Carcinoma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Nasopharyngeal Cancer Treatment.
Esthesioneuroblastoma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Esthesioneuroblastoma Treatment.
Thyroid Tumors
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Thyroid Cancer Treatment.
Sources: Childhood Thyroid Cancer Treatment
Oral Cavity Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Oral Cavity Cancer Treatment.
Salivary Gland Tumors
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Salivary Gland Tumors Treatment.
Laryngeal Cancer and Papillomatosis
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Laryngeal Tumors Treatment.
Sources: Childhood Laryngeal Tumors Treatment
NUT Carcinoma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood NUT Carcinoma Treatment.
Sources: Childhood NUT Carcinoma Treatment
Thoracic Cancers
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
The prognosis, diagnosis, classification, and treatment of pediatric thoracic cancers are discussed below. These cancers are seen very infrequently in patients younger than 15 years, and most of the evidence is derived from case series.
Rare pediatric thoracic cancers include the following:
Breast Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Breast Tumors Treatment.
Sources: Childhood Breast Tumors Treatment
Lung Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
Most pulmonary malignant neoplasms in children result from metastatic disease. The approximate ratio of primary malignant tumors to metastatic disease is 1:5.[1]
Sources: 1
The most common malignant primary tumors of the lung include the following:
Pulmonary inflammatory myofibroblastic tumors.
Tracheobronchial tumors.
Sources: Tracheobronchial tumors
Pleuropulmonary blastoma.
Sources: Pleuropulmonary blastoma
Pulmonary Inflammatory Myofibroblastic Tumors
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Pulmonary Inflammatory Myofibroblastic Tumors Treatment.
Sources: Childhood Pulmonary Inflammatory Myofibroblastic Tumors Treatment
Tracheobronchial Tumors
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Tracheobronchial Tumors Treatment.
Pleuropulmonary Blastoma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Pleuropulmonary Blastoma Treatment.
Esophageal Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Esophageal Cancer Treatment.
Thymoma and Thymic Carcinoma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Thymoma and Thymic Carcinoma Treatment.
Cardiac Tumors
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Cardiac Tumors Treatment.
Sources: Childhood Cardiac Tumors Treatment
Abdominal Cancers
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
The prognosis, diagnosis, classification, and treatment of pediatric abdominal cancers are discussed below. These cancers are seen very infrequently in patients younger than 15 years, and most of the evidence is derived from case series. For information about kidney tumors, see Wilms Tumor and Other Childhood Kidney Tumors Treatment.
Sources: Wilms Tumor and Other Childhood Kidney Tumors Treatment
Rare pediatric abdominal cancers include the following:
Adrenocortical Carcinoma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Adrenocortical Carcinoma Treatment.
Gastric Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Pediatric Gastric Cancer Treatment.
Sources: Pediatric Gastric Cancer Treatment
Pancreatic Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Pancreatic Cancer Treatment.
Colorectal Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Colorectal Cancer Treatment.
Gastrointestinal Neuroendocrine Tumors
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Pediatric Gastrointestinal Neuroendocrine Tumors Treatment.
Sources: Pediatric Gastrointestinal Neuroendocrine Tumors Treatment
Gastrointestinal Stromal Tumors (GIST)
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Gastrointestinal Stromal Tumors Treatment.
Sources: Childhood Gastrointestinal Stromal Tumors Treatment
Genital/Urinary Tumors
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
The prognosis, diagnosis, classification, and treatment of pediatric genital/urinary tumors are discussed below. These tumors are seen very infrequently in patients younger than 15 years, and most of the evidence is derived from case series.
Rare pediatric genital/urinary tumors include the following:
Bladder Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Bladder Cancer Treatment.
Sources: Childhood Bladder Cancer Treatment
Testicular Cancer (Non–Germ Cell)
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Testicular Cancer Treatment.
Ovarian Cancer (Non–Germ Cell)
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Ovarian Cancer Treatment.
Sources: Childhood Ovarian Cancer Treatment
Cervical and Vaginal Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Cervical and Vaginal Cancer Treatment.
Other Rare Childhood Cancers
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
The prognosis, diagnosis, classification, and treatment of other rare childhood cancers are discussed below. These cancers are seen very infrequently in patients younger than 15 years, and most of the evidence is derived from case series.
Other rare childhood cancers include the following:
Mesothelioma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Mesothelioma Treatment.
Sources: Childhood Mesothelioma Treatment
Multiple Endocrine Neoplasia (MEN) Syndromes
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Multiple Endocrine Neoplasia (MEN) Syndromes Treatment.
Sources: Childhood Multiple Endocrine Neoplasia (MEN) Syndromes Treatment
Pheochromocytoma and Paraganglioma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Pheochromocytoma and Paraganglioma Treatment.
Sources: Childhood Pheochromocytoma and Paraganglioma Treatment
Skin Cancer (Melanoma, Basal Cell Carcinoma [BCC], and Squamous Cell Carcinoma [SCC])
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information about specific genetic variants and related hereditary skin cancer syndromes, see Genetics of Skin Cancer. For information about uveal melanoma in children, see Childhood Intraocular (Uveal) Melanoma Treatment.
Sources: Genetics of Skin Cancer · Childhood Intraocular (Uveal) Melanoma Treatment
Melanoma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Melanoma Treatment.
Sources: Childhood Melanoma Treatment
BCC and SCC
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Basal Cell Carcinoma and Squamous Cell Carcinoma of the Skin Treatment.
Sources: Childhood Basal Cell Carcinoma and Squamous Cell Carcinoma of the Skin Treatment
Intraocular (Uveal) Melanoma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Intraocular (Uveal) Melanoma Treatment.
Chordoma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Chordoma Treatment.
Sources: Childhood Chordoma Treatment
Cancer of Unknown Primary (CUP) Site
Source: Rare Cancers of Childhood Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: September 27, 2024. Captured 2026-09-09.
For more information, see Childhood Cancer of Unknown Primary (CUP) Treatment.
Sources: Childhood Cancer of Unknown Primary (CUP) Treatment
General Information About Rare Cancers of Childhood
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
Key Points
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
Rare cancers of childhood are cancers not usually seen in children.
Rare cancers of childhood are cancers not usually seen in children.
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
Cancer in children and adolescents is rare. Since 1975, the number of new cases of childhood cancer has slowly increased. Since 1975, the number of deaths from childhood cancer has decreased by more than half.
Sources: childhood cancer
The cancers listed in this summary are so rare that most children's hospitals are likely to see less than a handful of some types in several years. Because these cancers are so rare, there is not a lot of information about what treatment works best. A child's treatment is often based on what has been learned from treating other children. Sometimes, information is available only from reports of the diagnosis, treatment, and follow-up of one child or a small group of children who were given the same type of treatment.
Molecular testing of tumors can sometimes help plan treatment. Children newly diagnosed with a rare cancer listed below may be eligible for molecular testing through the Molecular Characterization Initiative.
Sources: Molecular testing
The Molecular Characterization Initiative offers free molecular testing to children, adolescents, and young adults with certain types of newly diagnosed cancer. The program is offered through NCI's Childhood Cancer Data Initiative. To learn more, visit About the Molecular Characterization Initiative.
Many different cancers are listed in this summary. They are grouped by where they are found in the body.
The Rare Cancers of Childhood Treatment summary has been separated into individual summaries for each topic. Please use the lists below or visit the individual summaries at PDQ Cancer Information Summaries: Pediatric Treatment.
Sources: PDQ Cancer Information Summaries: Pediatric Treatment
Rare Cancers of the Head and Neck
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
Nasopharyngeal Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Nasopharyngeal Cancer.
Sources: Childhood Nasopharyngeal Cancer
Esthesioneuroblastoma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Esthesioneuroblastoma.
Sources: Childhood Esthesioneuroblastoma
Thyroid Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Thyroid Cancer.
Sources: Childhood Thyroid Cancer
Oral Cavity Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Oral Cavity Cancer.
Sources: Childhood Oral Cavity Cancer
Salivary Gland Tumors
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Salivary Gland Tumors.
Sources: Childhood Salivary Gland Tumors
Laryngeal Cancer and Papillomatosis
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Laryngeal Tumors.
Sources: Childhood Laryngeal Tumors
NUT Carcinoma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood NUT Carcinoma.
Sources: Childhood NUT Carcinoma
Rare Cancers of the Chest
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
Breast Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Breast Cancer Treatment.
Sources: Childhood Breast Cancer Treatment
Lung Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit:
Childhood Tracheobronchial Tumors
Sources: Childhood Tracheobronchial Tumors
Pleuropulmonary Blastoma
Sources: Pleuropulmonary Blastoma
Esophageal Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Esophageal Cancer.
Sources: Childhood Esophageal Cancer
Thymoma and Thymic Carcinoma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Thymoma and Thymic Carcinoma Treatment.
Heart Tumors
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Heart Tumors.
Sources: Childhood Heart Tumors
Rare Cancers of the Abdomen
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
Adrenocortical Carcinoma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Adrenocortical Carcinoma.
Sources: Childhood Adrenocortical Carcinoma
Stomach Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Stomach Cancer.
Sources: Childhood Stomach Cancer
Pancreatic Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Pancreatic Cancer Treatment.
Colorectal Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Colorectal Cancer Treatment.
Gastrointestinal Neuroendocrine Tumors
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Gastrointestinal Neuroendocrine Tumors Treatment.
Sources: Childhood Gastrointestinal Neuroendocrine Tumors Treatment
Gastrointestinal Stromal Tumors
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Gastrointestinal Stromal Tumors Treatment.
Sources: Childhood Gastrointestinal Stromal Tumors Treatment
Rare Cancers of the Reproductive and Urinary Systems
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
Bladder Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Bladder Cancer.
Sources: Childhood Bladder Cancer
Testicular Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Testicular Cancer.
Sources: Childhood Testicular Cancer
Ovarian Cancer
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Ovarian Cancer.
Sources: Childhood Ovarian Cancer
Cervical and Vaginal Cancers
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Cervical and Vaginal Cancers.
Other Rare Cancers of Childhood
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
Mesothelioma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Mesothelioma.
Sources: Childhood Mesothelioma
Multiple Endocrine Neoplasia Syndromes
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Multiple Endocrine Neoplasia (MEN) Syndromes Treatment.
Pheochromocytoma and Paraganglioma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Pheochromocytoma and Paraganglioma Treatment.
Sources: Childhood Pheochromocytoma and Paraganglioma Treatment
Skin Cancer (Melanoma, Basal Cell Carcinoma, and Squamous Cell Carcinoma of the Skin)
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit:
Childhood Melanoma Treatment
Sources: Childhood Melanoma Treatment
Childhood Basal Cell Carcinoma and Squamous Cell Carcinoma of the Skin Treatment
Sources: Childhood Basal Cell Carcinoma and Squamous Cell Carcinoma of the Skin Treatment
Intraocular (Uveal) Melanoma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Intraocular (Uveal) Melanoma Treatment.
Chordoma
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Chordoma.
Sources: Childhood Chordoma
Carcinoma of Unknown Primary
Source: Rare Cancers of Childhood Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 4, 2025. Captured 2026-09-09.
To learn more, visit Childhood Carcinoma of Unknown Primary Treatment.
Triangle